623 Process Intensification and Advanced Control of Pharmaceutical Processes


Description:
This session will include talks that demonstrate the use of advanced control approaches and process intensification techniques applied in drug substance and drug product manufacturing.

Sponsor:
Pharmaceutical Discovery, Development and Manufacturing Forum
Co-Sponsor(s):
Pharmaceuticals (15B), Process Intensification & Modular Chemical Processing (T8), Next-Gen Manufacturing (T6A)


Chair:
Dimitrios I. Gerogiorgis
Lecturer
University of Edinburgh
Institute for Materials and Processes (IMP), School of Engineering
The King's Buildings
Edinburgh
EH9 3JL
Phone Number: ARRAY(0xf707bd0)
Fax Number: +44131 650 6551
Email: D.Gerogiorgis@ed.ac.uk

Co-Chair:
Zoltan K. Nagy
Professor of Chemical Engineering
Purdue University
School of Chemical Engineering
480 Stadium Mall Drive
West Lafayette, IN
IN 47907-2100
Email: znagy@purdue.edu


Papers:
623a
Technoeconomic Evaluation of Cyclosporine Crystallisation Intensification Using a Cascade of M.S.M.P.R. Crystallisers
Samir Diab, University of Edinburgh; Dimitrios I. Gerogiorgis, University of Edinburgh
623b
Application of Advanced Process Control Tools in Continuous Processing
Stephan Sacher, Research Center Pharmaceutical Engineering; Jakob Rehrl, Research Center Pharmaceutical Engineering GmbH; Julia Kruisz, Research Center Pharmaceutical Engineering GmbH; Otto Scheibelhofer, Research Center Pharmaceutical Engineering GmbH; Isabella Aigner, Research Center Pharmaceutical Engineering; Michael Martinetz, Research Center Pharmaceutical Engineering GmbH; Patrick R. Wahl, Research Center Pharmaceutical Engineering GmbH; Johannes G. Khinast, Research Center Pharmaceutical Engineering GmbH
623c
Nonlinear First-Principle Model-Based Control of a Continuous Pharmaceutical Manufacturing Process
Nima Yazdanpanah, U.S. Food and Drug Administration; Thomas O'Connor, U.S. Food and Drug Administration; Naresh Pavurala, U.S. Food and Drug Administration; Sonal Mazumder, U.S. Food and Drug Administration; Muhammad Ashraf, U.S. Food and Drug Administration; Celia N. Cruz, U.S. Food and Drug Administration; Cassandra Taylor, U.S. Food and Drug Administration; Xiaoming Xu, U.S. Food and Drug Administration
623d
A Fault-Tolerant Control Design for Real-Time Release in Continuous Manufacturing of Solid Dose Using Direct Compaction
Qinglin Su, Purdue University; Mariana Moreno, Purdue University; Jianfeng Liu, Purdue University; Sudarshan Ganesh, Purdue University; Yasasvi Bommiready, Purdue University; Marcial Gonzalez, Purdue University; Gintaras V. Reklaitis, Purdue University; Zoltan K. Nagy, Purdue University; Thomas O'Connor, U.S. Food and Drug Administration; Geng Tian, Food and Drug Administration
623e
Intensified Crystallization of Sulfathiazole and Sulfanilamide By Direct Co-Crystal Assembly
Kuan-Lin Yeh, National Central University; Tu Lee, National Central University
623f
Direct Co-Crystal Assembly from Synthesis to Co-Crystallization
Ya-Chi Fan, National Central University; Hung-Lin Lee, National Central University; Tu Lee, National Central University
623g
Continuous Preparation of 1:1 Haloperidol-Maleic Acid Salt By a Novel Solvent-Free Method Using a Twin Screw Melt Extruder
Tu Lee, National Central University; Hung-Lin Lee, National Central University; Jaydip M. Vasoya, St. John’s University; Marilia de Lima Cirqueira, St. John’s University; Kuan-Lin Yeh, National Central University; Abu T. M. Serajuddin, St. John’s University
Abstract Submissions Closed
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum
<< Previous Session | Next Session >>